Molecular Diagnosis of SLC26A4,FOXI1 and KCNJ10 Gene in 35 Shanghai Probands with Non-Syndromic Hearing Loss Associated with Enlarged Vestibular Aqueduct

CHAI Yong-chuan,LI Xiao-hua,LI Lei,LI You-jin,LV Jing-rong,LI Yun,MA Yan,TAO Zheng,YANG Tao,WU Hao
DOI: https://doi.org/10.16150/j.1671-2870.2010.05.034
2010-01-01
Abstract:Objective To elucidate the molecular pathogenesis of non-syndromic hearing loss associated with enlarged vestibular aqueduct (EVA) in Shanghai, China by mutation screening of SLC26A4, FOXI1, KCNJ10 and SLC26A4 promoter c.-103 site. Methods DNA sample and clinical material were obtained from 35 unrelated EVA probands in Shanghai. The exons and the flanking splicing sites of SLC26A4 were screened in all probands by nested PCR and direct sequencing. Probands with zero or one mutation in the SLC26A4 coding region were further screened for FOXI1, KCNJ10 and SLC26A4 promoter c.-103 site. Results Twenty-three (66%) and 4 (11%) probands carried biallelic and monoallelic mutations of the SLC26A4 gene, respectively. A total of 13 types of SLC26A4 mutations were identified, with c.919-2AG and p.R409H mutations accounting for 64% (32/50) and 8% (4/50) of mutatant alleles, respectively. No mutation was detected in 8 (23%) probands. In all 12 (34%) probands with zero or one SLC26A4 mutation, no mutation was detected in FOXI1, KCNJ10 and SLC26A4 promoter c.-103 site. Conclusions Compared with previous reports concerning Chinese EVA patients, our results shows a significantly lower percentage of EVA patients in Shanghai having SLC26A4 mutations. This discrepancy indicates the genetic structure of Chinese population varies in different regions. We also shows that mutation in FOXI1, KCNJ10 and SLC26A4 promoter c.-103 site is not the major cause of EVA in Shanghai. Our study provided valuable information for the molecular diagnosis of EVA in Shanghai population.
What problem does this paper attempt to address?